BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 15963399)

  • 1. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).
    Parrinello G; Di Pasquale P; Torres D; Cardillo M; Schimmenti C; Lupo U; Iatrino R; Petrantoni R; Montaina C; Giambanco S; Paterna S
    Am Heart J; 2012 Sep; 164(3):351-7. PubMed ID: 22980301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure.
    Parrinello G; Paterna S; Di Pasquale P; Torres D; Mezzero M; Cardillo M; Fasullo S; La Rocca G; Licata G
    J Card Fail; 2011 Apr; 17(4):331-9. PubMed ID: 21440872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
    Paterna S; Fasullo S; Parrinello G; Cannizzaro S; Basile I; Vitrano G; Terrazzino G; Maringhini G; Ganci F; Scalzo S; Sarullo FM; Cice G; Di Pasquale P
    Am J Med Sci; 2011 Jul; 342(1):27-37. PubMed ID: 21701268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
    Tuttolomondo A; Pinto A; Di Raimondo D; Corrao S; Di Sciacca R; Scaglione R; Caruso C; Licata G
    Nutr Metab Cardiovasc Dis; 2011 May; 21(5):372-9. PubMed ID: 20346637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
    Licata G; Tuttolomondo A; Licata A; Parrinello G; Di Raimondo D; Di Sciacca R; Cammà C; Craxì A; Paterna S; Pinto A
    Aliment Pharmacol Ther; 2009 Aug; 30(3):227-35. PubMed ID: 19438847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
    Wan Y; Li L; Niu H; Ma X; Yang J; Yuan C; Mu G; Zhang J
    Int Heart J; 2017 Aug; 58(4):601-607. PubMed ID: 28701670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.
    Libetta C; Sepe V; Zucchi M; Pisacco P; Cosmai L; Meloni F; Campana C; Rampino T; Monti C; Tavazzi L; Dal Canton A
    Nephrol Dial Transplant; 2007 Jul; 22(7):2013-9. PubMed ID: 17298996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Dose Torasemide is Equivalent to High-Dose Furosemide with Hypertonic Saline in the Treatment of Refractory Congestive Heart Failure.
    Paterna S; Fasullo S; Di Pasquale P
    Clin Drug Investig; 2005; 25(3):165-73. PubMed ID: 17523765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure.
    Paterna S; Parrinello G; Amato P; Dominguez L; Pinto A; Maniscalchi T; Cardinale A; Licata A; Amato V; Licata G; Di Pasquale P
    Adv Ther; 1999; 16(5):219-28. PubMed ID: 10915397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
    Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
    Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.
    Palazzuoli A; Silverberg DS; Iovine F; Calabrò A; Campagna MS; Gallotta M; Nuti R
    Am Heart J; 2007 Oct; 154(4):645.e9-15. PubMed ID: 17892986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.